Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

USA - NASDAQ:BYRN - US12448X2018 - Common Stock

19.97 USD
-0.34 (-1.67%)
Last: 9/12/2025, 8:00:02 PM
20.0001 USD
+0.03 (+0.15%)
After Hours: 9/12/2025, 8:00:02 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BYRN. BYRN was compared to 69 industry peers in the Aerospace & Defense industry. BYRN has an excellent financial health rating, but there are some minor concerns on its profitability. BYRN shows excellent growth, but is valued quite expensive already. These ratings would make BYRN suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year BYRN was profitable.
In the past year BYRN has reported a negative cash flow from operations.
In the past 5 years BYRN reported 4 times negative net income.
In multiple years BYRN reported negative operating cash flow during the last 5 years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

BYRN has a Return On Assets of 19.09%. This is amongst the best in the industry. BYRN outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 24.59%, BYRN belongs to the best of the industry, outperforming 92.75% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.65%, BYRN belongs to the top of the industry, outperforming 92.75% of the companies in the same industry.
Industry RankSector Rank
ROA 19.09%
ROE 24.59%
ROIC 12.65%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

BYRN's Profit Margin of 14.28% is amongst the best of the industry. BYRN outperforms 91.30% of its industry peers.
BYRN has a better Operating Margin (9.60%) than 60.87% of its industry peers.
The Gross Margin of BYRN (61.88%) is better than 95.65% of its industry peers.
BYRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.6%
PM (TTM) 14.28%
GM 61.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BYRN is still creating some value.
The number of shares outstanding for BYRN has been increased compared to 1 year ago.
The number of shares outstanding for BYRN has been increased compared to 5 years ago.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 17.14 indicates that BYRN is not in any danger for bankruptcy at the moment.
The Altman-Z score of BYRN (17.14) is better than 95.65% of its industry peers.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 17.14
ROIC/WACC1.3
WACC9.7%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

BYRN has a Current Ratio of 3.63. This indicates that BYRN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BYRN (3.63) is better than 81.16% of its industry peers.
A Quick Ratio of 1.53 indicates that BYRN should not have too much problems paying its short term obligations.
The Quick ratio of BYRN (1.53) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.63
Quick Ratio 1.53
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1450.00% over the past year.
BYRN shows a strong growth in Revenue. In the last year, the Revenue has grown by 73.55%.
The Revenue has been growing by 147.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)73.55%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%40.63%

3.2 Future

The Earnings Per Share is expected to grow by 15.78% on average over the next years. This is quite good.
The Revenue is expected to grow by 18.79% on average over the next years. This is quite good.
EPS Next Y-35.18%
EPS Next 2Y5.92%
EPS Next 3Y15.78%
EPS Next 5YN/A
Revenue Next Year36.4%
Revenue Next 2Y28.83%
Revenue Next 3Y29.15%
Revenue Next 5Y18.79%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.21, BYRN can be considered very expensive at the moment.
Based on the Price/Earnings ratio, BYRN is valued a bit cheaper than the industry average as 71.01% of the companies are valued more expensively.
BYRN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 28.71 indicates a quite expensive valuation of BYRN.
Based on the Price/Forward Earnings ratio, BYRN is valued a bit cheaper than the industry average as 65.22% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.73. BYRN is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 32.21
Fwd PE 28.71
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BYRN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 36.96
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

BYRN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BYRN's earnings are expected to grow with 15.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.92%
EPS Next 3Y15.78%

More info and screens

0

5. Dividend

5.1 Amount

BYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (9/12/2025, 8:00:02 PM)

After market: 20.0001 +0.03 (+0.15%)

19.97

-0.34 (-1.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-10 2025-07-10/bmo
Earnings (Next)10-09 2025-10-09/bmo
Inst Owners59.52%
Inst Owner Change9.43%
Ins Owners19.32%
Ins Owner Change0.07%
Market Cap453.32M
Analysts83.64
Price Target39.27 (96.64%)
Short Float %22.75%
Short Ratio6.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.56%
Min EPS beat(2)21.04%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)104.71%
Min EPS beat(4)21.04%
Max EPS beat(4)254.68%
EPS beat(8)6
Avg EPS beat(8)-36.83%
EPS beat(12)8
Avg EPS beat(12)-9.3%
EPS beat(16)9
Avg EPS beat(16)-27.67%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)1.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.75%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)1.52%
Revenue beat(8)4
Avg Revenue beat(8)4.49%
Revenue beat(12)4
Avg Revenue beat(12)-1.24%
Revenue beat(16)5
Avg Revenue beat(16)-1.7%
PT rev (1m)0%
PT rev (3m)8.07%
EPS NQ rev (1m)3.13%
EPS NQ rev (3m)-27.07%
EPS NY rev (1m)12.57%
EPS NY rev (3m)14.2%
Revenue NQ rev (1m)1.18%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)3.59%
Valuation
Industry RankSector Rank
PE 32.21
Fwd PE 28.71
P/S 4.38
P/FCF N/A
P/OCF N/A
P/B 7.54
P/tB 8.29
EV/EBITDA 36.96
EPS(TTM)0.62
EY3.1%
EPS(NY)0.7
Fwd EY3.48%
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS4.56
BVpS2.65
TBVpS2.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.09%
ROE 24.59%
ROCE 16.01%
ROIC 12.65%
ROICexc 16%
ROICexgc 18%
OM 9.6%
PM (TTM) 14.28%
GM 61.88%
FCFM N/A
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score6
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 289.39%
Cap/Sales 5.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.63
Quick Ratio 1.53
Altman-Z 17.14
F-Score6
WACC9.7%
ROIC/WACC1.3
Cap/Depr(3y)202.29%
Cap/Depr(5y)309.93%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y-35.18%
EPS Next 2Y5.92%
EPS Next 3Y15.78%
EPS Next 5YN/A
Revenue 1Y (TTM)73.55%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%40.63%
Revenue Next Year36.4%
Revenue Next 2Y28.83%
Revenue Next 3Y29.15%
Revenue Next 5Y18.79%
EBIT growth 1Y407.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year223.74%
EBIT Next 3Y91.87%
EBIT Next 5Y53.44%
FCF growth 1Y-58.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.81%
OCF growth 3YN/A
OCF growth 5YN/A